Skip to main content

Daniel MacKinnon Joins LSPedia as Vice President, Sales & Marketing

By November 11, 2022November 29th, 2022Company News, Employees, News
Daniel MacKinnon, VP of Sales & Marketing

Meet Daniel MacKinnon, the newest member of LSPedia’s Leadership Team!

Daniel is a dynamic, innovative, and award-winning sales and marketing leader with more than a decade of experience in building and growing technology companies in highly regulated industries. In addition to sales and marketing expertise, Daniel brings critical analysis skills and a talent for simplifying complex concepts and executing comprehensive go-to-market strategies. At LSPedia, he’ll drive strategy and growth for sales and marketing operations, reporting to CEO Riya Cao.

“For businesses across the pharma supply chain, LSPedia is as much a lifesaving resource as a partner,” he said. “What our team puts in front of trading partners is not just software and serialization technology, but DSCSA expertise and supply chain optimization at every level, and that makes our work vital. I’m happy to be leading this team in a crucial phase and a crucial year for the industry.”

The biggest differentiator for LSPedias flagship software OneScan has always been its creation with pharmaceutical workflows to enable accurate, fast, and automated operations with turnkey compliance. As serialized products move downstream to pharmacies and hospitals, OneScan gives these businesses the serialization technology to support their workflows without adding complexity and cost. With OneScan, pharmacies and hospitals can meet the FDA’s DSCSA compliance requirements while benefiting from a technology upgrade that can digitalize inventory, streamline recalls, and improve patient care. 

Cao commented, “In the last 10 years, Daniel has worked intensively in providing technology solutions to healthcare systems. He is one of the few executives with hands-on experience in helping health systems remove waste and achieve efficiency. Daniel will help our customers cut through the confusion and pressure, meet FDA compliance, and operate in the new serialization era with a clear, secure, and growth-minded view.” 

Welcome, Daniel!

Do you have questions for Daniel or our other experts? Contact our team or write to [email protected].